Keywords: serono, clarity, trial, starts, enrolling, swiss, biotechnology

Serono's US CLARITY trial starts enrolling

Article | 15 May 2006

Swiss biotechnology group Serono has started recruitement for the Phase III USA-based CLAdRIbine Tablets in Treating MS OrallY Study (CLARITY), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cladribine

Leustatin

Amino Acids

Injection

Nystatin

Go to drug listing